A mutation in the p53 tumor suppressor gene of AHH-1 tk(+/-) human lymphoblastoid cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 356, Issue 2, 1996, Pages 129-134

  Morris, Suzanne M ^a   Manjanatha, Mugimane G ^a   Shelton, Sharon D ^a   Domon, Olen E ^a   McGarrity, Lynda J ^a   Casciano, Daniel A ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

AGG 1 tk(+ ) human lymphoblastoid cell; CpG mutation; MCL 5 human lymphoblastoid cell; p53 mutation

Indexed keywords

PROTEIN P53;

ARTICLE; CELL CULTURE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOLECULAR GENETICS; MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0030599162     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(96)00133-9     Document Type: Article

References (33)

1. Baker, S.J., E.R. Fearon, J.M. Nigro, S.R. Hamilton, A.C. Preisinger, J.J. Milburn, P. van Tuinen, D.H. Ledbetter, D.F. Baker, Y. Nakamura, R. White and B. Vogelstein (1989) Chromosome deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217-221.
2. Bargonetti, J., J.J. Manfredi, X. Chen, D.R. Marshak and C. Prives. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev., 7, 2565-2574.
3. Canman, C.E. and M.B. Kastan (1995) Induction of apoptosis by tumor suppressor genes and oncogenes. Semin. Cancer Biol., 6, 17-25.
4. Crespi, C.L. and W.G. Thilly (1984) Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism. Mutation Res., 128, 221-230.
5. Crespi, C.L., G.M. Seixas, T. Turner and B.W. Gelboin (1990) Sodium fluoride is a less efficient mutagen at low concentrations. Environ. Mol. Mutagen., 15, 71-77.
6. Crespi, C.L., F.J. Gonzalez, D.T. Steimel, T.R. Turner, H.V. Gelboin, B.W. Penman and R. Langenbach (1991) A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem. Res. Toxicol., 4, 566-572.
7. Dobo, K.L., C.R. Giver, D.A. Eastmond, H.S. Rumbos and A.J. Grosovsky. (1995) Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human lymphoblasts. Mutagenesis, 10, 53-58.
8. Ford, J.M. and P.C. Hanawalt (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA, 92, 8876-8880.
9. Gaidano, G., P. Ballerini, J.Z. Gong, G. Inghirami, A. Neri, E.W. Newcomb, I.T. Magrath, D.M. Knowles and R. Dalla-Favera (1991) p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 88, 5413-5417.
10. Greenblatt, M.S., W.P. Bennett, M. Hollstin and C.C. Harris (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
11. Hollstin, M., D.S. Sidransky, B. Vogelstein and C.C. Harris (1991) p53 mutations in human cancers. Science, 253, 49-53.
12. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein and R.W. Craig (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
13. Lane, D.P. and S. Benchimol (1990) p53: oncogene or anti-oncogene? Genes and Develop., 4, 1-8.
14. Lotem, J. and L. Sachs (1995) A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. Proc. Natl. Acad. Sci. USA, 92, 9672-9676.
15. Lowe, S.W., S. Bodis, N. Bardeesy, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, T. Jacks, J. Pelletier and D.E. Houseman (1994) Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harbour Symp. Quant. Biol., 59, 419-426.
16. Milner, J. and E.A. Medcalf (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell, 65, 765-774.
17. Milner, J., E.A. Medcalf and A.C. Cook (1991) Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes. Mol. Cell. Biol., 11, 12-19.
18. Morris, S.M., L.J. McGarrity, O.E. Domon, J.J. Chen, W.G. Hinson, T.J. Bucci, A.R. Warbritton and D.A. Casciano (1994) The role of programmed cell death in the toxicity of the mutagens, ethyl methanesulfonate and N-ethyl-N'-nitrosourea, in AHH-1 human lymphoblastoid cells. Mutation Res., 306, 19-34.
19. Morris, S.M., O.E. Domon, L.J. McGarrity, J.J. Chen and D.A. Casciano (1995) Programmed cell death and mutation induction in AHH-1 human lymphoblastoid cells exposed to m-amsa. Mutation Res., 329, 79-96.
20. +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa. Environ. Mol. Mutagen., 27, 10-18.
21. +/- human lymphoblastoid cells. Mutation Res., in press.
22. Nigro, J.M., S.J. Baker, A.C. Preisinger, J.J. Milburn, R. Hostetter, K. Cleary, S.H. Bigner, N. Davidson, S. Baylin, P. Devilee, T. Glover, F.S. Collins, A. Watson, R. Modali, C.C. Harris and B. Vogelstein (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature, 342, 705-708.
23. Orita, M., Y. Suzuki, T. Sekiya and K. Hayashi (1989) Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics, 5, 874-879.
24. Radford, I.R. (1994) p53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and myeloid cell lines. Int. J. Rad. Biol., 5, 557-560.
25. Rideout, W.M., G.A. Coetzee, A.F. Olumi and P.A. Jones (1990) 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science, 249, 1288-1290.
26. Rosselli, F., A. Ridet, T. Soussi, E. Duchard, C. Alapetite and E. Moustacchi (1995) p53-dependent pathway of radio-induced apopotisis is altered in Fanconi anemia. Oncogene, 10, 9-17.
27. Sambrook, J., E.F. Fritsch and T. Maniatis (1989) Isolation of high molecular weight DNA from mammalian cells. in: Molecular Cloning: A laboratory manual, 2nd Edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 916-919.
28. Schwartz, J.L., R. Jordan, B.A. Sedita, M.L. Swenningson, J.P. Banath and P.L. Olive (1995) Different sensitivity to cell killing and chromosome mutation induction by gamma rays in two human lymphoblastoid cell lines derived from a single donor: possible role of apoptosis. Mutagenesis, 10, 227-233.
29. Takahashi, T., M.M. Nau, I. Chiba, M.J. Birrer, R.K. Rosenberg, M. Vinocur, M. Levitt, H. Pass, A.F. Gazdar, J.D. Minna (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494.
30. Tornaletti, S. and G.P. Pfeifer (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene, 10, 1493-1499.
31. 1 arrest after irradiation. Oncogene, 11, 141-149.
32. Wyllie, A.H., P.J. Carder, A.R. Clarke, K.J. Cripps, S. Geldhill, F. Greaves, S. Griffiths, D.J. Harrison, M.L. Hooper, R.G. Morris, C.A. Purdie and C.C. Bird (1994) Apoptosis in carcinogenesis: The role of p53. Cold Spring Harbour Symp. Quant. Biol., 59, 403-409.
33. Xia, F., X. Wang, N.M. Tsang, D.W. Yandell, K.T. Kelsy and H.L. Liber (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res., 55, 12-15.